Garriga-Baraut, T. et al. 2024. A real-life ImmunoCAT study: impact of molecular diagnosis through ImmunoCAPTM ISAC 112 on immunotherapy prescription in pollen-polysensitized patients in Catalonia, Spain. Allergologia et Immunopathologia. 52, 4 (Jul. 2024), 21–29. DOI:https://doi.org/10.15586/aei.v52i4.1077.